Partnership
Institut Curie partner of Transgene myvac, an individualized immunotherapy against solid tumors
09/24/2018
News
Here you will find our latest press releases and news
Innovation
Institut Curie announces creation of Honing Biosciences
09/13/2018
Partnership
Sanofi Announces Funding of 19 Innovative Research Projects through its New European Academic Awards Program
07/09/2018
Partnership
Nanobiotix announces positive phase II/III topline data in soft tissue sarcoma with nbtxr3
06/22/2018
Partnership
Institut Curie and Gataca-Systems: More than 10 years of collaboration and promising years ahead
06/19/2018
Partnership
Institut Curie names Intel lead partner to implement high performance computing and artificial intelligence in accelerating genome sequencing and interpretation for oncology
05/22/2018
DNA Thearpeutics was acquired in 2016 by ONXEO. First-in-class, signal-interfering DNA molecule based on one of the most promising new approaches in cancer treatment
www.onxeo.com
Innovation
Onxeo Announces Initiation of DRIIV Phase I Clinical Trial of AsiDNA™ for Treatment of Advanced Solid Tumor
04/24/2018
Developing microfluidic solutions to make microfluidics easy
https://www.fluigent.com
Partnership
The HoliFAB project, led by Fluidgent, a spin-off from Institut Curie, wins €7.1 million in funding.
04/18/2018
Partnership
PEP-Therapy, Institut Curie and Gustave Roussy obtain 2,9 M€ to develop a novel peptide in oncology
04/16/2018
Partnership
Institut Curie and Mirada Medical sign a collaboration agreement for the clinical use of DLCExpert™, Mirada’s artificial intelligence (AI)-based autocontouring software for radiation therapy
04/11/2018